# NEUBASE THERAPEUTICS INC (NBSEXXXX)

> Institutional ownership reported to the SEC as of Q3 2023, from Form 13F filings. Source: https://holderbook.com/stocks/NBSEXXXX/

- Reporting holders: 1
- Reported value: $40.9K
- Held through calls: 0.0%
- Held through puts: 0.0%

A 13F reports long US equity positions only. Shorts, bonds, foreign listings and cash are not visible here, and positions are disclosed up to 45 days after the quarter ends.

## Largest holders

| Manager | Value | Shares | Share of their book | Quarters held |
|---|---|---|---|---|
| [CARNEGIE MELLON UNIVERSITY](https://holderbook.com/funds/1039067-carnegie-mellon-university/) | $40.9K | 46,970 | 0.1% | 8 |

## Quarter by quarter

| Quarter | Holders | Reported value |
|---|---|---|
| Q3 2023 | 1 | $40.9K |
| Q2 2023 | 3 | $180.8K |
| Q1 2023 | 35 | $1.7M |
| Q4 2022 | 32 | $1.9M |
| Q3 2022 | 36 | $4.7M |
| Q2 2022 | 36 | $13.4M |
| Q1 2022 | 43 | $23.3M |
| Q4 2021 | 44 | $31.8M |
| Q3 2021 | 47 | $36.8M |
| Q2 2021 | 56 | $52.1M |
| Q1 2021 | 56 | $59.5M |
| Q4 2020 | 53 | $49.4M |